TELA Bio, Inc. TELA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.24% | -35.75% | -5.09% | 13.30% | 11.91% |
| Total Depreciation and Amortization | 0.76% | 17.33% | -9.27% | -8.15% | 1.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.89% | -26.95% | 35.18% | 50.04% | -25.39% |
| Change in Net Operating Assets | 135.29% | -205.41% | 103.01% | 53.68% | 163.39% |
| Cash from Operations | 16.02% | -129.36% | 14.85% | 27.65% | 18.71% |
| Capital Expenditure | 50.42% | -30.77% | 56.87% | -85.09% | -256.25% |
| Sale of Property, Plant, and Equipment | -3.56% | 9.19% | -45.89% | 64.47% | 87.06% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 25.79% | -1.04% | -38.46% | 52.94% | 47.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -99.76% | 26,173.33% | -- | -100.00% |
| Repurchase of Common Stock | 81.01% | -1,875.00% | 80.95% | -600.00% | 98.31% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 93.05% | -- | -- | -- |
| Cash from Financing | 94.97% | -101.15% | 107,587.50% | 900.00% | 97.41% |
| Foreign Exchange rate Adjustments | 61.54% | 25.71% | -133.65% | 168.42% | -13.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.90% | -153.49% | 500.30% | 32.80% | 20.14% |